Linker Capital Management’s Bristol-Myers Squibb BMY Stock Holding History

Linker Capital Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$518K	Hold	8,101	–	–	0.53%	26
2023 Q1	$561K	Hold	8,101	–	–	0.62%	27
2022 Q4	$583K	Hold	8,101	–	–	0.67%	27
2022 Q3	$576K	Sell	8,101 -161	-2%	-$11.7K	0.71%	25
2022 Q2	$636K	Sell	8,262 -10	-0.1%	-$762	0.79%	22
2022 Q1	$604K	Hold	8,272	–	–	0.6%	29
2021 Q4	$516K	Buy	+8,272	New	+$485K	0.5%	32

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Linker Capital Management's BMY Position: Q2 2023 in Review

Linker Capital Management held its Bristol-Myers Squibb (BMY) position steady in Q2 2023 at 8,101 shares worth $518K. The position accounts for 0.53% of the portfolio, ranked #26.

Linker Capital Management first reported a position in BMY in Q4 2021 and has held it in 7 quarters since. The position peaked at $636K in Q2 2022. 2,481 funds tracked by Wall St. Rank hold BMY as of Q2 2023.

Linker Capital Management held 8,101 shares of Bristol-Myers Squibb worth $518K as of Q2 2023.
Linker Capital Management left its Bristol-Myers Squibb share count unchanged in Q2 2023.
Bristol-Myers Squibb made up 0.53% of Linker Capital Management's portfolio in Q2 2023, its #26 holding.
Linker Capital Management first reported a position in Bristol-Myers Squibb in Q4 2021 and has held it in 7 quarters since.
Linker Capital Management's Bristol-Myers Squibb position peaked at $636K in Q2 2022.
2,481 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2023.

Based on Linker Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.